Latest Insider Transactions at Bio Cardia, Inc. (BCDA)
This section provides a real-time view of insider transactions for Bio Cardia, Inc. (BCDA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of BioCardia, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of BioCardia, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 31
2021
|
Jay M Moyes Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,456
+5.99%
|
-
|
|
Mar 31
2021
|
Richard M Krasno Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,024
+6.02%
|
-
|
|
Mar 31
2021
|
Andrew Scott Blank Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,752
+3.13%
|
-
|
|
Mar 31
2021
|
Krisztina M Zsebo Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,736
+47.87%
|
-
|
|
Dec 31
2020
|
Krisztina M Zsebo Director |
BUY
Grant, award, or other acquisition
|
Direct |
244
+50.0%
|
-
|
|
Dec 31
2020
|
Richard C Pfenniger Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,925
+5.55%
|
-
|
|
Dec 31
2020
|
Andrew Scott Blank Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,643
+2.64%
|
-
|
|
Dec 31
2020
|
Jim L. Allen Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,534
+0.41%
|
-
|
|
Dec 31
2020
|
Jay M Moyes Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,550
+6.24%
|
-
|
|
Dec 31
2020
|
Richard M Krasno Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,534
+6.08%
|
-
|
|
Dec 31
2020
|
Simon H Stertzer Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,768
+1.42%
|
-
|
|
Dec 01
2020
|
Peter Altman President and CEO |
BUY
Open market or private purchase
|
Direct |
1,000
+0.48%
|
$2,000
$2.49 P/Share
|
|
Nov 27
2020
|
Peter Altman President and CEO |
BUY
Open market or private purchase
|
Direct |
3,200
+1.53%
|
$6,400
$2.37 P/Share
|
|
Nov 27
2020
|
Peter Altman President and CEO |
SELL
Open market or private sale
|
Direct |
3,200
-1.55%
|
$6,400
$2.31 P/Share
|
|
Nov 13
2020
|
Peter Altman President and CEO |
BUY
Open market or private purchase
|
Direct |
500
+0.24%
|
$1,000
$2.09 P/Share
|
|
Nov 12
2020
|
Peter Altman President and CEO |
BUY
Open market or private purchase
|
Direct |
2,000
+0.96%
|
$4,000
$2.06 P/Share
|
|
Nov 10
2020
|
Peter Altman President and CEO |
BUY
Open market or private purchase
|
Direct |
2,500
+1.21%
|
$2,500
$1.98 P/Share
|
|
Nov 02
2020
|
Eric Duckers Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
8,435
-41.1%
|
$16,870
$2.01 P/Share
|
|
Sep 30
2020
|
Simon H Stertzer Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,968
+1.5%
|
-
|
|
Sep 30
2020
|
Richard C Pfenniger Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,125
+6.36%
|
-
|
|
Sep 30
2020
|
Jay M Moyes Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,750
+7.81%
|
-
|
|
Sep 30
2020
|
Richard M Krasno Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,734
+6.61%
|
-
|
|
Sep 30
2020
|
Fernando L Fernandez Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,968
+6.81%
|
-
|
|
Sep 30
2020
|
Andrew Scott Blank Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,843
+3.47%
|
-
|
|
Sep 30
2020
|
Jim L. Allen Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,734
+0.4%
|
-
|